Gain-of-function (GOF) mutations in the PCSK9 gene have been identified as a genetic cause of familial hypercholesterolemia, with numerous such mutations reported (5, 6), increasing the risk for atherosclerotic cardiovascular diseases such as coronary artery disease (CAD), cerebrovascular disease, and peripheral atherosclerosis. This evidence concerns the gene PCSK9 and coronary artery disorder.